pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    dilanubicel
    dilanubicel
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Deverra Therapeutics Inc
  • Phase 2
    dimesna
    dimesna [INN]
    Non-Small Cell Lung Cancer$LTRN Lantern Pharma Inc.
  • Phase 2
    dinutuximab beta
    dinutuximab beta [INN]
    Ewing Sarcoma Recordati SpA
  • Phase 2
← prev
page 14 of 21
next →
131
Pain89
Neurology1
disitamab vedotin
disitamab vedotin
Metastatic Transitional (Urothelial) Tract Cancer
$PFE PFIZER INC
  • Phase 2
    disufenton sodium
    disufenton sodium
    Recurrent Malignant Glioma Oblato Inc
  • Phase 2
    divesiran
    divesiran [INN]
    Polycythemia Vera$SLN Silence Therapeutics plc
  • Phase 2
    dorocubicel
    dorocubicel
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Cordex Biologics Inc
  • Phase 2
    dubodencel
    dubodencel [INN]
    Glioblastoma Multiforme (GBM) Diakonos Oncology Corp
  • Phase 2
    durvalumab + IPH-5201
    Non-Small Cell Lung Cancer$AZN ASTRAZENECA PLC
  • Phase 2
    efarindodekin alfa
    efarindodekin alfa[INN]
    Cervical Cancer$GILD GILEAD SCIENCES, INC.
  • Phase 2
    efgitasialase alfa
    efgitasialase alfa
    Breast Cancer Palleon Pharmaceuticals Inc
  • Phase 2
    efineptakin alfa
    efineptakin alfa
    Radiation Toxicity (Radiation Sickness, Acute Radiation S… NeoImmuneTech Inc
  • Phase 2
    elironrasib
    elironrasib
    Non-Small Cell Lung Cancer$RVMD Revolution Medicines, Inc.
  • Phase 2
    elisrasib
    elisrasib [INN]
    Solid Tumor D3 Bio Inc
  • Phase 2
    elraglusib
    elraglusib
    Neuroblastoma$ACTU ACTUATE THERAPEUTICS, INC.
  • Phase 2
    eltivutabart
    eltivutabart [INN]
    Pancreatic Ductal Adenocarcinoma Trishula Therapeutics Inc
  • Phase 2
    elzovantinib
    elzovantinib
    Non-Small Cell Lung Cancer Bristol-Myers Squibb Co
  • Phase 2
    endoxifen
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$ATOS ATOSSA THERAPEUTICS, INC.
  • Phase 2
    eniluracil
    eniluracil
    Metastatic Breast Cancer$PCSA Processa Pharmaceuticals, Inc.
  • Phase 2
    enozertinib
    enozertinib [INN]
    Solid Tumor$ORIC Oric Pharmaceuticals, Inc.
  • Phase 2
    enzomenib tartrate
    enzomenib tartrate
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Sumitomo Pharma Co Ltd
  • Phase 2
    epsametostat
    epsametostat [INN]
    Peripheral T-Cell Lymphomas (PTCL) Shanghai Haihe Biopharma Co Ltd
  • Phase 2
    etigilimab
    etigilimab
    Adenocarcinoma Of The Gastroesophageal Junction$MREO Mereo BioPharma Group plc
  • Phase 2
    etivelcabtagene erigedleucel
    etivelcabtagene erigedleucel
    Follicular Lymphoma Cellectis SA
  • Phase 2
    evalstotug
    evalstotug [INN]
    Melanoma$BCAB BioAtla, Inc.
  • Phase 2
    evarucabgene autoleucel
    evarucabgene autoleucel
    Refractory Multiple Myeloma Nexcella Inc
  • Phase 2
    ezurpimtrostat
    ezurpimtrostat [INN]
    Bile Duct Cancer (Cholangiocarcinoma) Genfit SA
  • Phase 2
    farletuzumab ecteribulin
    farletuzumab ecteribulin
    Triple-Negative Breast Cancer (TNBC) Eisai Co Ltd
  • Phase 2
    fenretinide
    fenretinide
    Dengue Fever$ILPLF Island Pharmaceuticals Ltd
  • Phase 2
    fexapotide triflutate
    fexapotide triflutate
    Prostate Cancer$NYMXF NYMOX PHARMACEUTICAL CORP